Form 8-K - Current report:
SEC Accession No. 0001193125-25-157388
Filing Date
2025-07-10
Accepted
2025-07-10 07:53:24
Documents
13
Period of Report
2025-07-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d15137d8k.htm   iXBRL 8-K 29768
2 EX-99.1 d15137dex991.htm EX-99.1 19106
  Complete submission text file 0001193125-25-157388.txt   176218

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20250708.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20250708_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20250708_pre.xml EX-101.PRE 11692
16 EXTRACTED XBRL INSTANCE DOCUMENT d15137d8k_htm.xml XML 3815
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 251114843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)